BOSTON, March 29, 2018 -- Starburst, the Presto company, today released its Enterprise Distribution of Presto, Version 195e, with the open source query engine’s first Cost-Based Optimizer (CBO). The company also introduced PrestoCare™, Starburst’s managed service offering for customers that want to leverage the power of Presto without the administrative burden.
“Leading internet companies including Facebook, Airbnb, Netflix, Twitter and Uber already benefit from Presto’s performance, but Starburst’s new CBO is another giant leap forward for this open source project,” said Justin Borgman, co-founder at Starburst. “Internal performance testing and customer benchmarking show a greater than 10x performance improvement for many analytical queries such as those in TPC-H and TPC-DS.”
Starburst’s release featuring the new CBO is now available online for download at: https://www.starburstdata.com/download/.
PrestoCare, a fully managed Presto service, is also available now, enabling customers to focus on their core business while leaving Presto administration to the experts. Starburst’s highly experienced team leverages industry best practices to optimize Presto environments for peak performance, while providing new levels of stability and efficiency.
Learn more about PrestoCare here:
https://www.starburstdata.com/presto-managed-services.
ABOUT STARBURST
Starburst was founded by many of the leading developers of the open source Presto project. Starburst’s Enterprise Distribution of Presto provides analysts with the ability to perform fast, interactive queries on data wherever data lives, including popular sources such as HDFS, S3-compatible object stores, MySQL, Microsoft SQL Server, PostgreSQL, Cassandra, MongoDB, Kafka, and Teradata, among others.
To learn more about Presto or to download the latest version of Starburst’s distribution, please visit starburstdata.com.
Starburst and the Starburst logo are trademarks or registered trademarks of Starburst Data, Inc.
Media Contact:
Larry Bouchie, TurboPR
[email protected]
781-620-0278


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



